[ad_1]
It turned out that 6 samples with the British strain of coronavirus “came” from Vilkaviškis, 4 – from Kaunas and 1 – from Marijampolė.
In total, there are already 12 known cases in the country where people have been infected with the British strain of the virus. The first patient is fine now.
SAM also reports that a total of 284 samples were analyzed this week. Kaunas Clinics has already examined the 96 samples mentioned above, another 188 samples are being analyzed by the reference laboratory of the European Center for Disease Prevention and Control. Results from this foreign laboratory are expected in the near future.
We remind you that in order to monitor the diversity, prevalence and changes in the genome of the COVID-19 strains found in Lithuania, the coronavirus genome sequencing process has been launched at the national level. These tests will be initiated with the help of national laboratories equipped to carry out the tests.
The National Public Health Laboratory (NSAID) is responsible for organizing and coordinating the large-scale coronavirus genome sequencing process.
Samples with a British Coronavirus Strain Were Obtained Last Week – Clinical Guide
The Kaunas Clinical Laboratory received eleven samples of the British strain of coronavirus last week, says Renaldas Jurkevičius, general manager of the hospital.
According to him, most of the 96 samples were received from the National Public Health Laboratory (NSPL), the rest, samples taken in the emergency department of LSMU Kaunas Clinics.
“Last week, we received 96 samples, we did the sequencing, and in 85 of them, the genome was successfully obtained from those 96. Of these 85, a British strain was identified,” R. Jurkevičius told BNS on Wednesday.
“All those cases are not from the Kaunas clinics: six are from the Vilkaviškis Hospital, one from Marijampolė county and four from the Kaunas county mobile points,” he said.
According to him, during the sequencing of the virus, the laboratory does not know the history of the patients, their condition or how the samples were selected.
“We get randomly selected samples from NVSPL, just to reflect that population and know that distribution,” said the director of the Kaunas clinics.
It is true that all the samples that the laboratories had to analyze in this batch were from the Kaunas region.
R. Jurkevičius assured that the Clinics reported on the patients at Vilkaviškis Hospital, and NVSPL will have to identify the patients examined at the mobile points, because their data is still encrypted.
[ad_2]
